Aubrey de Grey and James Strole look ahead to RA

‘Social wellness’ provider to offer custom-f

Abu Dhabi biotech collaboration aims to fast-tra

How mapping the ‘effectome’ allows General P

New funding follows impressive vision restoratio

A year-long study in healthy adults suggests sex

Subsense CEO on hacking the brain, treating neur

Companies to combine MEG and EEG tech to bring c

Treatment provides continuous dopaminergic stimu

TMEM65 found to support calcium clearance in cel

Partnership focuses on platform that enables dru

New book explores how an overlooked saturated fa

Agenda explores diagnostics, age reversal and pr

I Peace offers individuals the opportunity to pr

Clinical trial met all key endpoints, demonstrat

Nicola Marino, Director of AEON Foundation, on t

Junevity founder explains how developments in si

Startup leverages cultivated muscle tissue gener

Company demonstrates treatment with intravenous

Professionals across insurance, pensions and res

Plasma biomarker measuring tau tangles aids diag

Company’s ‘precise and reversible’ RNA-edi

Company’s ‘precise and reversible’ RNA-edi

Rejuve Longevity users can monetize their health

Company to expand multi-ancestry biobank to supp

Survey of 82 clinics highlights technology uptak

Startup aims for clinical trial of lead candidat

Eighteen-month expedition sets out to examine lo

ThirdLaw Molecular is developing a new class of

Trial aims to demonstrate capacity to extend hea

Landmark conference concludes with call for unif

ARMMs technology expands scope of potential epig

Research highlights role of C15:0 in cellular re

Company says senolytic therapeutic delivers ‘r

Startup boasts pipeline of candidates targeting

Participants saw gains in strength, immune funct

Human Longevity pledges $1 million for advanced

TruDiagnostic Founder Ryan Smith on personalized

Epigenetic reprogramming startup identifies mult

New RNAi therapeutic offers a novel mechanism to

Startup aims for clinical trials of microglia-ta

Study suggests anti-amyloid treatment may halve

Elevant’s best-selling biohacking product prov

Company to initiate clinical study of gene-silen

Sens.

Portuguese defender invests more than €1 milli

Longevity startup offers AI-powered blood biomar

New research finds that endothelial TDP-43 loss

Progress in spinal cord injury lays the foundati

London is the setting for the next edition of a